NCT05723497

Completed

Elderberries and Obesity

Washington State University Source

Compare

Other study identifiers

Sponsor study identifier

18682

Study Type

interventional

Actual enrollment (reported)

10

Locations

1 country

Sites

1

Timeline

Study Start

July 27, 2021

Actual (reported)

Primary Completion

September 2, 2022

Actual (reported)

Study Completion

September 2, 2022

Actual (reported)

Brief Summary

Previous studies in humans indicate that anthocyanin-rich berries can positively alter fat oxidation and insulin sensitivity. This study will determine if this is also true with elderberries, which are a more concentrated source of anthocyanins compared to other commonly consumed berries.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 10 participants
Study completion date: September 2, 2022
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
July 20, 2021
Actual (reported)
Study Start
July 27, 2021
Actual (reported)
Primary Completion
September 2, 2022
Actual (reported)
Study Completion
September 2, 2022
Actual (reported)
First Posted
February 10, 2023
Actual (reported)

Last Updated: February 10, 2023
Status Verified: February 2023
Last Update Submitted: February 8, 2023

Conditions

Fuel Management

Outcome Measures

Primary Outcomes (2)

Substrate oxidation
Participants will be monitored by a metabolic cart at rest and while walking
3.5 hours
Glucose tolerance/insulin sensitivity
Blood will be collected following a meal tolerance test
3 hours

Study Arms (2)

Elderberry juice

EXPERIMENTAL

Participants will consume elderberry juice twice/day for 1-week.

Other: Elderberry juice

Placebo beverage

PLACEBO COMPARATOR

Participants will consume placebo beverage twice/day for 1-week.

Other: Placebo beverage

Interventions

Elderberry juiceOther

Participants will consume elderberry juice 1-week.

Elderberry juice

Placebo beverageOther

Participants will consume placebo for 1-week.

Placebo beverage

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age22 Years - 75 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Women and Men between 22 and 75 years of age with a body mass index of 25 kg/m2 or above.

You may not qualify if:

Sponsors & Collaborators

Washington State University
Otherlead

Study Sites (1)

Nutrition and Exercise Physiology

Spokane, Washington, 99202, United States

Enrollment

10 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: DOUBLE
Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
Purpose: PREVENTION
Intervention Model: CROSSOVER
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Assistant Professor

Study Record Dates

First Submitted

July 20, 2021

First Posted

February 10, 2023

Study Start

July 27, 2021

Actual (reported)

Are not fully vaccinated against COVID-19 (at least 2-weeks out from final dose at time of staff meeting)

Have a body mass index less than 25 kg/m2

Are younger than 22 years of age, or older than 75 years of age

Pregnant, lactating, or intending to become pregnant during the study period, or have given birth in the past year

Known allergy or intolerance to elderberries

History of bariatric surgery or nutrient malabsorption disease (such as celiac disease) or other metabolic disorders requiring a special diet that is not in accord with the diet behavior requested for this study

Adherence to restrictive (vegetarian or vegan) or extreme (fad \[ex. Ketogenic or Atkins\] or quick weight loss/gain) diet patterns and unwillingness to consume a conventional, omnivorous diet and maintain body weight

Habitual use of tobacco or marijuana (including vaping) products in the last 6 months

Diagnosis or treatment of cancer in the past 3 years

Crohn's disease or diverticulitis

Suspected or known strictures, fistulas or physiological/mechanical GI obstruction

Use of certain medications (prescription or over-the-counter) that may interfere with the study objectives, including blood thinning medications

Type 2 diabetes requiring the use of medication

Fasting blood glucose \> 125 mg/dL

Unable or unwilling to give informed consent or communicate with study staff

+1 more criteria

Contact the study team to confirm eligibility.

Primary Completion

September 2, 2022

Actual (reported)

Study Completion

September 2, 2022

Actual (reported)

Last Updated

February 10, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT05723497
Data provider: ClinicalTrials.gov
Source updated: 2023-02-10
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:38:36 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

Primary Completion

Study Completion

First Posted

Conditions

Outcome Measures

Primary Outcomes (2)

Study Arms (2)

Elderberry juice

Placebo beverage

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations